Takeda Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 6

- Investments
- 128
- Portfolio
- 61
- Exits
- 38

Takeda Ventures General Information
Description
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited based in San Diego, California. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, oncology sectors in the United States, Western Europe, and Canada.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
- 9625 Towne Centre Drive
- San Diego, CA 92121
- United States
+1 (619) 000-0000
Takeda Ventures Investments (128)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
hC Bioscience | 23-Feb-2022 | Early Stage VC | 0000 | Drug Discovery | Startup | 00000 0000 |
0000000 000000 | 07-Feb-2022 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 0000000 000000 00.0 |
00000 000000000 | 21-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Product Development | |
0000000 0000000000 | 02-Dec-2021 | 00000 00000 | 00.000 | Discovery Tools (Healthcare) | Generating Revenue | 00000 000000 00 |
0000 000000000000 | 22-Oct-2021 | 00000 00000 | 000.00 | Drug Discovery | Startup | 00000 0000 |
00000 000000000000 | 14-Jul-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000000 00 00000 00.0 |
000000000 00000000 | 14-Jul-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
00000000 000000000 | 01-Jun-2021 | 0000 00000 | 000.00 | Biotechnology | Product In Beta Test | 000000 0000000 00.0 |
BridGene Biosciences | 05-May-2021 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue | |
Code Bio | 20-Apr-2021 | Seed Round | 0000 | Biotechnology | Generating Revenue | 000000 00000 00 |
Takeda Ventures Exits (38)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Arcellx | 04-Feb-2022 | IPO | 00000 |
00000 000000000000 | 22-Oct-2021 | 000 | 00000 |
00000000 000000000 | 01-Oct-2021 | 000000000000000000 | 00000 |
00 000000000000 | 24-Sep-2021 | 000 00 00000000 | |
00000000 | 18-Dec-2020 | 000000000000000000 | 00.00 |
000000 00000000000 | 15-Dec-2020 | 000000000000000000 | |
00000000 0000 | 09-Oct-2020 | 000 | 00000 |
0000000 0000000000 | 12-Jun-2020 | 000 | 00000 |
Petra Pharma | 14-May-2020 | Merger/Acquisition | |
ArmaGen | 20-Apr-2020 | Merger/Acquisition |
Takeda Ventures Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialTakeda Ventures Team (18)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Robbie Woodman Ph.D | Senior Partner | 00 | 0 | San Diego, CA | |
Sacha Mann | Senior Partner | 0 | 0 | San Diego, CA | |
Miles Gerson JD | Senior Investment Director & Partner | 0 | 0 | San Diego, CA | |
Alessandra Di Bacco Ph.D | Partner | 0 | 0 | Cambridge, MA | |
Bruce Meadows | Managing Partner & Director | 0 | 0 | San Diego, CA |
Takeda Ventures Co-Investors (213)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
OrbiMed | 8 | 0 | 0 |
![]() |
![]() |
Alexandria Venture Investments | 0 | 0 |
![]() |
![]() |
|
Johnson & Johnson Innovation - JJDC | 0 | 0 |
![]() |
![]() |
|
SV Health Investors | 0 | 0 |
![]() |
![]() |
|
Novartis Venture Fund | 0 | 0 |
![]() |
![]() |